Therapeutic potential of targeting ceramide for early cardiometabolic lipotoxicity in vivo study.

Sci Rep · 2025 · PMC12800147 · PMID 41392183

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Notably, Group III exhibited a reduction in CerC24:1 level compared to the NC group, though these changes did not reach statistical significance relative to the HFD group (Group II) (Table S2).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.